NODinh – Novel specific NOD2 inhibitors with anti-inflammatory properties
Pharmacological inhibition of inflammatory responses in humans is pivotal in a wide variety of disease states. A prominent protein associated with inflammatory processes in general is NOD2. Polymorphisms in the NOD2 gene correlate with several specific inflammatory disorders such as Crohn`s disease, Blau syndrome and early onset sarcoidosis.
The present invention provides innovative small molecules that are potentially beneficial not only for the treatment of genetic disorders, but also for the treatment of bacterially induced inflammations in humans. Data suggest that, in comparison to currently available antiphlogistics, a therapeutic application of the inventive compounds is associated with a significantly reduced side-effect-profile. Furthermore, the compounds can be used as starting points for anti-inflammatory drug discovery.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 10
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Making diamonds at ambient pressure
Scientists develop novel liquid metal alloy system to synthesize diamond under moderate conditions. Did you know that 99% of synthetic diamonds are currently produced using high-pressure and high-temperature (HPHT) methods?[2]…
Eruption of mega-magnetic star lights up nearby galaxy
Thanks to ESA satellites, an international team including UNIGE researchers has detected a giant eruption coming from a magnetar, an extremely magnetic neutron star. While ESA’s satellite INTEGRAL was observing…
Solving the riddle of the sphingolipids in coronary artery disease
Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new…
